Literature DB >> 23890363

The relationship between nicotine cessation and mental disorders in a nationally representative sample.

Sean Donald1, Hayley Chartrand, James M Bolton.   

Abstract

The objective of this study was to examine the relationship between Axis I and II mental disorders, quality of life, and nicotine dependence cessation in a nationally representative sample. Data came from Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), a nationally representative survey of adults in the United States (N = 34,653). People who met DSM-IV criteria for nicotine dependence previously but who had abstained from nicotine in the last year (nicotine cessation) were compared to people currently dependent on nicotine as well as lifetime abstainers using multivariate logistic regression. Outcomes of interest included DSM-IV Axis I and II mental disorders, treatment seeking for mental disorders, and quality of life measures. In adjusted models, individuals who ceased nicotine use in the last year were less likely to have past-year mood [adjusted odds ratio (AOR) = 0.64; 95% confidence interval (CI) 0.50-0.82, p < 0.001] and substance use disorders (AOR = 0.65, 95% CI 0.52-0.82, p < 0.001) compared to those with current nicotine dependence. They were also less likely to have narcissistic and borderline personality disorders. Compared to those with current nicotine dependence, cessation was associated with an improved quality of life, both physically (beta = 1.65; standard error 0.40, p < 0.001) and mentally (beta = 2.17, standard error 0.39, p < 0.001). In conclusion, nicotine dependence cessation was associated with reduced likelihood of several mental disorders and a higher quality of life compared to those with current nicotine dependence. These findings provide further support for public health policy aimed at smoking cessation.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Comorbidity; Epidemiology; Mental disorder; Nicotine dependence; Quality of life; Smoking cessation

Mesh:

Year:  2013        PMID: 23890363     DOI: 10.1016/j.jpsychires.2013.05.011

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  7 in total

1.  Methods to reduce false reporting of substance abstinence in clinical research.

Authors:  Sandra J Japuntich; Kimberly A Arditte Hall; Celina M Joos; Ann M Rasmusson; Suzanne L Pineles
Journal:  Int J Methods Psychiatr Res       Date:  2018-01-04       Impact factor: 4.035

2.  Lifetime Depression, Other Mental Illness, and Smoking Cessation.

Authors:  Amanda L Huffman; Julie E Bromberg; Erik M Augustson
Journal:  Am J Health Behav       Date:  2018-07-01

3.  Tobacco-related knowledge following a comprehensive tobacco-free workplace program within behavioral health facilities: Identifying organizational moderators.

Authors:  Lorra Garey; Clayton Neighbors; Isabel Martinez Leal; Cho Y Lam; William T Wilson; Bryce Kyburz; Tim Stacey; Virmarie Correa-Fernández; Teresa Williams; Michael J Zvolensky; Lorraine R Reitzel
Journal:  Patient Educ Couns       Date:  2019-04-10

4.  Influence of Psychiatric and Personality Disorders on Smoking Cessation Among Individuals in Opiate Dependence Treatment.

Authors:  Nina A Cooperman; Shou-En Lu; Kimber P Richter; Steven L Bernstein; Jill M Williams
Journal:  J Dual Diagn       Date:  2016-04-11

5.  Smoking cessation is associated with lower rates of mood/anxiety and alcohol use disorders.

Authors:  P A Cavazos-Rehg; N Breslau; D Hatsukami; M J Krauss; E L Spitznagel; R A Grucza; P Salyer; S M Hartz; L J Bierut
Journal:  Psychol Med       Date:  2014-09       Impact factor: 7.723

6.  Predicting smoking and nicotine dependence from the DSM-5 alternative model for personality pathology.

Authors:  Alexandra L Halberstadt; Carillon J Skrzynski; Aidan G C Wright; Kasey G Creswell
Journal:  Personal Disord       Date:  2021-03-11

7.  Depression, anxiety, stress, and motivation over the course of smoking cessation treatment.

Authors:  Maritza Muzzi Cardozo Pawlina; Regina de Cássia Rondina; Mariano Martinez Espinosa; Clóvis Botelho
Journal:  J Bras Pneumol       Date:  2015 Sep-Oct       Impact factor: 2.624

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.